Synthesis and molecular modelling studies of pyrimidinones and pyrrolo[34-d]-pyrimidinodiones as new antiplasmodial compounds

BACKGROUND Malaria is responsible for 429,000 deaths per year worldwide, and more than 200 million cases were reported in 2015. Increasing parasite resistance has imposed restrictions to the currently available antimalarial drugs. Thus, the search for new, effective and safe antimalarial drugs is crucial. Heterocyclic compounds, such as dihydropyrimidinones (DHPM), synthesised via the Biginelli multicomponent reaction, as well as bicyclic compounds synthesised from DHPMs, have emerged as potential antimalarial candidates in the last few years. METHODS Thirty compounds were synthesised employing the Biginelli multicomponent reaction and subsequent one-pot substitution/cyclisation protocol; the compounds were then evaluated in vitro against chloroquine-resistant Plasmodium falciparum parasites (W2 strain). Drug cytotoxicity in baseline kidney African Green Monkey cells (BGM) was also evaluated. The most active in vitro compounds were evaluated against P. berghei parasites in mice. Additionally, we performed an in silico target fishing approach with the most active compounds, aiming to shed some light into the mechanism at a molecular level. RESULTS The synthetic route chosen was effective, leading to products with high purity and yields ranging from 10-84%. Three out of the 30 compounds tested were identified as active against the parasite and presented low toxicity. The in silico study suggested that among all the molecular targets identified by our target fishing approach, Protein Kinase 3 (PK5) and Glycogen Synthase Kinase 3β (GSK-3β) are the most likely molecular targets for the synthesised compounds. CONCLUSIONS We were able to easily obtain a collection of heterocyclic compounds with in vitro anti-P. falciparum activity that can be used as scaffolds for the design and development of new antiplasmodial drugs.

Computer Aided Drug Designing

Designing of drugs and their development are a time and resource consuming process. There is an increasing effort to introduce the role of computational approach to chemical and biological space in order to organise the design and development of drugs and their optimisation. The role of Computer Aided Drug Designing (CADD) are nowadays expressed in Nanotechnology, Molecular biology, Biochemistry etc. It is a diverse discipline where various forms of applied and basic researches are interlinked with each other. Computer aided or in Silico drug designing is required to detect hits and leads. Optimise/ alter the absorption, distribution, metabolism, excretion and toxicity profile and prevent safety issues. Some commonly used computational approaches include ligand-based drug design, structure-based drug design, and quantitative structure-activity and quantitative structure-property relationships. In today's world, due to an avid interest of regulatory agencies and, even pharmaceutical companies in advancing drug discovery and development process by computational means, it is expected that its power will grow as technology continues to evolve. The main purpose of this review article is to give a brief glimpse about the role Computer Aided Drug Design has played in modern medical science and the scope it carries in the near future, in the service of designing newer drugs along with lesser expenditure of time and money

Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors

Reverse transcriptase (RT) is a multifunctional enzyme in the human immunodeficiency virus (HIV)-1 life cycle and represents a primary target for drug discovery efforts against HIV-1 infection. Two classes of RT inhibitors, the nucleoside RT inhibitors (NRTIs) and the nonnucleoside transcriptase inhibitors are prominently used in the highly active antiretroviral therapy in combination with other anti-HIV drugs. However, the rapid emergence of drug-resistant viral strains has limited the successful rate of the anti-HIV agents. Computational methods are a significant part of the drug design process and indispensable to study drug resistance. In this review, recent advances in computer-aided drug design for the rational design of new compounds against HIV-1 RT using methods such as molecular docking, molecular dynamics, free energy calculations, quantitative structure-activity relationships, pharmacophore modelling and absorption, distribution, metabolism, excretion and toxicity prediction are discussed. Successful applications of these methodologies are also highlighted.

Modelo molecular teórico del receptor serotoninérgico 5HT2A acoplado a proteína G / Theoretical molecular model of the G protein-coupled 5HT2A serotonergic receptor / Modelo molecular teórico do receptor serotoninérgico 5-HT2A acoplado à proteína G

Objetivo. Construir un modelo molecular teórico de la estructura terciara del receptor 5HT2A de Homo sapiens a partir de estructurasobtenidas experimentalmente como plantillas. Materiales y métodos. Para la realización del modelo teórico se contempló el protocoloestablecido por Ballesteros y Weinstein para la construcción del receptor acoplado proteína G, por medio de alineamiento de la secuenciade aminoácidos, perfiles de hidrofobicidad, refinamiento de bucles por restricciones espaciales, y minimización de energía con el campode fuerza OPLS_2005. Resultados. El modelo obtenido fue validado por el gráfico de Ramachandran con un 91,7% de aminoácidosdentro de los límites establecidos para ángulos phi y psi, y un RMSD de 0,95 Å con respecto a rodopsina de bovino. Conclusiones. Seobtuvo un modelo teórico validado, útil para realización de estudios de acoplamiento ligando-receptor...

Objective Build a theoretical molecularmodel of the tertiary structure of the Homo sapiens 5HT2A receptor from experimentally obtained structures as templates. Materialsand methods In the construction of the theoretical model we considered the protocol established by Ballesteros and Weinstein for theconstruction of the G-protein coupled receptor, by the alignment of the amino acid sequence, hydrophobicity profiles, refinement ofloops by spatial restrictions and energy minimization with the force field OPLS_2005. Results The resulting model was validated bythe Ramachandran plot with 91.7% of amino acids within the limits set for angles phi and psi and a RMSD of 0.95 Å with respect tobovine rhodopsin. Conclusions We obtained a validated theoretical model useful in studies of ligand-receptor docking...

Objetivo. Construir um modelo molecularteórico da estrutura terciária do receptor 5HT2A de Homo Sapiens, com estruturas obtidas experimentalmente como moldes. Materiaise métodos. Para a elaboração do modelo teórico se utilizou o protocolo estabelecido por Ballesteros e Weinstein para a construção doreceptor acoplado à proteína G, por intermédio de alinhamento da seqüência de aminoácidos, perfis de hidrofobicidade, refinamento debucles por restrições espaciais e minimização da energia com o campo de força OPLS_2005. Resultados. O modelo obtido foi validadopelo gráfico de Ramachandran com 91,7% dos aminoácidos dentro dos limites estabelecidos para os ângulos phi e psi, e um RMSD de0,95 Å com respeito à rodopsina de bovino. Conclusões. Obteve-se um modelo teórico validado, útil para a realização de estudos deacoplamento ligante-receptor...

The conformations and energetics of photodamaged DNA.

Energy minimization techniques are used in conjunction with the results of small molecule crystallographic studies on relevant compounds to propose structural models for photodamaged DNAs. Specifically, we present models both for a DNA molecule containing a psoralen photo-crosslink and for a DNA molecule containing a thymine photodimer. In both models, significant distortions of the nucleic acid helix are observed, including kinking and unwinding at the damage site and numerous changes in the backbone torsion angles relative to their standard conformations. Both the torsion angle geometries and the energetics of the models are presented in detail.